4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001219036-20-000004
Chief Scientific Officer returned 13,385 shares (to the company)
- Chief Scientific Officer acquired 32,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LANCHBURY JERRY S Chief Scientific Officer | 2020-09-24 | Grant or award | +32,800 | 226,308 | D: show line 1 in the form | ||
| LANCHBURY JERRY S Chief Scientific Officer | 2020-09-25 | Returned to the company | −5,544 | $12.44 | $68,967 | 220,764 | D: show line 2 in the form |
| LANCHBURY JERRY S Chief Scientific Officer | 2020-09-25 | Returned to the company | −4,214 | $12.44 | $52,422 | 216,550 | D: show line 3 in the form |
| LANCHBURY JERRY S Chief Scientific Officer | 2020-09-26 | Returned to the company | −3,627 | $12.44 | $45,120 | 212,923 | D: show line 4 in the form |
Loading xslF345X03/edgardoc.xml…